Through the modulation of PP2A/Akt/FoxO3a pathway, CAPN2 silencing induces the expression of cyclin-dependent p27Kip1 kinase inhibitor and reduces breast carcinoma cell proliferation (Ho et al., 2012). The gene discussed is CAPN2; the disease is breast carcinoma.